Search results for "Note"

showing 10 items of 10709 documents

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in…

2005

An open-label randomised comparison of efficacy and tolerability of irinotecan plus high-dose 5-fluorouracil (5-FU) and leucovorin (LV) (ILF) with etoposide plus 5-FU/LV (ELF) in patients with untreated metastatic or locally advanced gastric cancer. One cycle of ILF comprised six once-weekly infusions of irinotecan 80 mg m(-2), LV 500 mg m(-2), 24-h 5-FU 2000 mg m(-2), and ELF comprised three once-daily doses of etoposide 120 mg m(-2), LV 300 mg m(-2), 5-FU 500 mg m(-2). In all, 56 patients received ILF and 58 ELF. Median age was 62 years, Karnofsky performance 90%, and disease status was comparable for both arms. The objective clinical response rates after 14 weeks treatment (primary end p…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.drug_classLeucovorinPhases of clinical researchNeutropeniaAdenocarcinomaIrinotecanAntimetaboliteGastroenterologygastricStomach NeoplasmsInternal medicineClinical StudiesAntineoplastic Combined Chemotherapy ProtocolsMedicineHumans5-fluorouracilStomach cancerEtoposidePeritoneal NeoplasmsAgedEtoposideNeoplasm StagingLevoleucovorinbusiness.industryMiddle Agedmedicine.diseaseSurvival AnalysisSurgerymetastaticIrinotecanELFTreatment OutcomeOncologyTolerabilityFluorouracilCamptothecinFemaleEsophagogastric JunctionFluorouracilbusinessILFmedicine.drugBritish Journal of Cancer
researchProduct

Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac.

2019

Determination of bioequivalence remains a challenge in generic topical drug development. To support pharmacokinetic studies, strategies to demonstrate microstructure sameness of the products being compared include in vitro evaluations, such as the comparison of rheological properties, droplet size and in vitro release rates. Nevertheless, defining the appropriate acceptance range to consider equivalence between test and reference formulation is complex. To shed more light into this issue, in vitro release and rheological properties were compared to in vivo bioequivalence data (systemic blood measurements within a clinical trial) after topical application of a single dose. Test and reference…

AdultMaleDiclofenacAdolescentAdministration TopicalPharmaceutical ScienceBiological Availability02 engineering and technologyBioequivalence030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicineDiclofenacPharmacokineticsRheologyIn vivomedicineHumansMathematicsTopical drugCross-Over StudiesMiddle Aged021001 nanoscience & nanotechnologyIn vitroBioavailabilityTherapeutic EquivalencyArea Under CurveFemale0210 nano-technologyRheologyBiomedical engineeringmedicine.drugInternational journal of pharmaceutics
researchProduct

Justification of Biowaiver for Carbamazepine, a Low Soluble High Permeable Compound, in Solid Dosage Forms Based on IVIVC and Gastrointestinal Simula…

2009

The aim of the present study was to use gastrointestinal simulation technology and in vitro-in vivo correlation (IVIVC) as tools to investigate a possible extension of biowaiver criteria to BCS class II drugs using carbamazepine (CBZ) as a candidate compound. Gastrointestinal simulation based on the advanced compartmental absorption and transit model implemented in GastroPlus was used. Actual in vitro and in vivo data generated in CBZ bioequivalence studies were used for correlation purposes. The simulated plasma profile, based on the CBZ physicochemical and pharmacokinetic properties, was almost identical with that observed in vivo. Parameter sensitivity analysis (PSA) indicated that the p…

AdultMaleDrugAbsorption (pharmacology)media_common.quotation_subjectPharmaceutical Science02 engineering and technologyBioequivalencePharmacologyModels BiologicalSensitivity and Specificity030226 pharmacology & pharmacyDosage form03 medical and health sciences0302 clinical medicineIVIVCPharmacokineticsRisk FactorsIn vivoDrug DiscoverymedicineHumansComputer SimulationIVIVCmedia_commonbioequivalenceChromatographyChemistrygastrointestinal simulationCarbamazepine021001 nanoscience & nanotechnologyBCSGastrointestinal TractCarbamazepineSolubilitycarbamazepineMolecular MedicineFemale0210 nano-technologyTabletsmedicine.drugMolecular Pharmaceutics
researchProduct

A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations

2019

Characterization of dissolution of solid suspended drug particles in vivo is important for developing biopredictive in vitro tests. Therefore, methods to gain deeper insights into particle dissolution in vivo are needed. The soft Bioperm intubation method, a well established tool for investigation of permeability, absorption, metabolism, and drug interactions at predefined locations in the gastroinstinal tract, was modified. The novel intubation method involved pump-controlled infusion of pharmaceutical suspensions as well as simultaneous pH monitoring. This technique was used in a proof of concept study in healthy humans. Plasma sampling and non-compartmental analysis allowed comparison of…

AdultMaleDrugDuodenumDrug Compoundingmedia_common.quotation_subjectPharmaceutical ScienceCapsulesIbuprofen02 engineering and technology030226 pharmacology & pharmacyPh monitoringIntestinal absorptionYoung Adult03 medical and health sciences0302 clinical medicineSuspensionsPharmacokineticsIn vivomedicineHumansIntubation GastrointestinalDissolutionInfusion Pumpsmedia_commonChromatographyChemistryAnti-Inflammatory Agents Non-SteroidalGeneral MedicineHydrogen-Ion Concentration021001 nanoscience & nanotechnologyIbuprofenPharmaceutical SolutionsIntestinal AbsorptionFemaleParticle size0210 nano-technologyBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Fixed dental prostheses with vertical tooth preparations without finish lines: A report of two patients

2016

Tooth abutments can be prepared to receive fixed dental prostheses with different types of finish lines. The literature reports different complications arising from tooth preparation techniques, including gingival recession. Vertical preparation without a finish line is a technique whereby the abutments are prepared by introducing a diamond rotary instrument into the sulcus to eliminate the cementoenamel junction and to create a new prosthetic cementoenamel junction determined by the prosthetic margin. This article describes 2 patients whose dental abutments were prepared to receive ceramic restorations using vertical preparation without a finish line.

AdultMaleEngineeringDentistryDental Abutments02 engineering and technology03 medical and health sciences0302 clinical medicinestomatognathic systemDental AbutmentsmedicineHumansGingival recessionCrownsbusiness.industryA diamond030206 dentistryFinish lineMiddle Aged021001 nanoscience & nanotechnologyIncisorstomatognathic diseasesCementoenamel junctionDental Prosthesis DesignFemaleDental Prosthesis Implant-SupportedTooth PreparationsOral Surgerymedicine.symptom0210 nano-technologybusinessThe Journal of Prosthetic Dentistry
researchProduct

Effect of implant macro-design on primary stability: A prospective clinical study

2016

Background Implant restorations have become a high predictable treatment option. Several caracteristics such as surgical technique and implant design can influence the treatment outcomes. The aim of the present study was to evaluate the influence of implant macro-design on primary stability measured with resonance frequency analysis (RFA) and insertion torque (IT). Material and Methods A total of 47 implants divided in two groups: Test group (TI): 22 Tapered MIS® Seven implants; Control group (CI): 25 cylindrical Astra® Osseospeed implants. All implants were inserted following the manufacturers’ standard protocols. Implant primary stability was measured at the moment of implant placement by…

AdultMaleInsertion torquemedicine.medical_specialtyTreatment outcomeDentistryOdontología02 engineering and technologyDental Prosthesis Retention03 medical and health sciences0302 clinical medicineDental Prosthesis DesignmedicineHumansProspective StudiesGeneral DentistryDental Implantsbusiness.industryResearchImplant design030206 dentistry:CIENCIAS MÉDICAS [UNESCO]021001 nanoscience & nanotechnologyDenture RetentionCiencias de la saludSurgeryResonance frequency analysisDental Prosthesis DesignOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASProspective clinical studyFemaleSurgeryImplantOral Surgery0210 nano-technologybusinessDental Prosthesis RetentionMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Comparison of peri-implant bone loss between conventional drilling with irrigation versus low-speed drilling without irrigation

2016

Background To compare the technique of high speed drilling with irrigation and low speed drilling without irrigation in order to evaluate the success rate and peri-implant bone loss at 12 months of follow-up. Material and Methods A randomized, controlled, parallel-group clinical trial was carried out in patients requiring dental implants to rehabilitate their unitary edentulism. Patients were recruited from the Oral Surgery Unit of the University of Valencia (Spain) between September 2014 and August 2015. Patients who met the inclusion criteria were randomized to two groups: group A (high-speed drilling with irrigation) and group B (low-speed drilling without irrigation). The success rate a…

AdultMaleIrrigationTime FactorsAlveolar Bone LossDentistryTherapeutic irrigation02 engineering and technologylaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineRandomized controlled triallawHumansMedicineTherapeutic IrrigationGeneral DentistryAgedAged 80 and overEdentulismbusiness.industryResearchDental Implantation EndosseousDrilling030206 dentistryMiddle Aged021001 nanoscience & nanotechnologymedicine.disease:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyLow speedMaxillaUNESCO::CIENCIAS MÉDICASFemaleSurgeryImplantOral Surgery0210 nano-technologybusinessFollow-Up Studies
researchProduct

Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a p…

2008

This is a phase II institutional exploratory trial of biweekly irinotecan and cetuximab administration regimen in metastatic colorectal cancer patients progressing to at least one previous chemotherapy line. A total of 40 patients were treated between November 2005 and November 2007 with irinotecan 180 mg m−2 and cetuximab 500 mg m−2 q2w (every 2 weeks), in every 21-day cycles, until unacceptable toxicity or progressive disease. An overall response rate of 22.5% was obtained (two complete and seven partial responses). The disease control rate was 60%. The time to progression was 3.4 months and the overall survival was 8 months. The toxicity compared very favourably to weekly cetuximab combi…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCetuximabAntibodies Monoclonal HumanizedIrinotecanDrug Administration ScheduleInternal medicineAntineoplastic Combined Chemotherapy ProtocolsClinical StudiesmedicineHumansProspective StudiesNeoplasm MetastasisAdverse effectAgedChemotherapyCetuximabbusiness.industrymetastatic colorectal cancerbiweekly scheduleAntibodies MonoclonalMiddle Agedmedicine.diseaseSurgeryClinical trialIrinotecanRegimenOncologyCamptothecinFemaleColorectal NeoplasmsbusinessProgressive diseasemedicine.drugBritish Journal of Cancer
researchProduct

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal c…

2003

The combination of irinotecan (CPT-11), bolus 5-fluorouracil (5-FU) and folinic acid (FA) (Saltz regimen) has recently been questioned as first-line chemotherapy for metastatic colorectal cancer after high early death rates due to gastrointestinal and thromboembolic events were reported in two US trials. Therefore, we carefully evaluated the safety and efficacy of this regimen, with high value placed on the management of delayed diarrhea. Forty-six patients with metastatic colorectal cancer received this first-line treatment in nine German outpatient clinics. Dose reductions were mandatory from the first cycle in case of toxicity grade2. Chemotherapy was administered only to diarrhea-free p…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentLeucovorinEarly deathIrinotecanFolinic acidBolus (medicine)Internal medicineAntineoplastic Combined Chemotherapy ProtocolsAmbulatory CaremedicineHumansPharmacology (medical)Prospective StudiesAgedPharmacologyChemotherapybusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseasedigestive system diseasesSurgerySurvival RateIrinotecanOncologyFluorouracilCamptothecinFemaleFluorouracilFirst line chemotherapyColorectal Neoplasmsbusinessmedicine.drugAnti-Cancer Drugs
researchProduct

Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients With Pretreated Advanced Pancreatic Carcinoma

2010

Patients with advanced pancreatic cancer failing gemcitabine-based first-line chemotherapy are still in relatively good clinical conditions and may still require second-line chemotherapy, which is frequently administered in daily clinical practice given to without solid scientific support.A retrospective survey was carried out including 40 patients with stage III or IV gemcitabine-refractory pancreatic carcinoma. Patients received standard FOLFIRI regimen biweekly until progression or unacceptable toxicity. Response evaluation criteria in solid tumors and National Cancer Institute common toxicity criteria were employed respectively for response and toxicity assessment.Six partial responses …

AdultMaleOncologyCancer Researchmedicine.medical_specialtyDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentLeucovorinIrinotecanBolus (medicine)Pancreatic cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFOLFIRI RegimenHumansPancreatic carcinomaAgedRetrospective StudiesChemotherapybusiness.industryMiddle Agedmedicine.diseaseSurvival AnalysisGemcitabinePancreatic NeoplasmsIrinotecanOncologyFluorouracilCamptothecinFemaleFluorouracilbusinessmedicine.drugAmerican Journal of Clinical Oncology
researchProduct